Therefore, our findings provide novel insights into the molecular mechanisms involved in HPV16 E6-induced oncogenesis and suggest that targeting ST6GAL1 or cGMP–PKG signaling might be potential therapeutic strategies for cervical cancer. This evidence concerns the gene ST6GAL1 and cervical cancer.